Difference between revisions of "Team:Waterloo"

m
m
Line 6: Line 6:
 
             <div class="col-sm-5">
 
             <div class="col-sm-5">
 
                 <img src="/wiki/images/5/5e/Waterloo_crispier_logo_transparent.png" alt="Waterloo iGEM CRISPieR Logo" class="img-responsive"/>
 
                 <img src="/wiki/images/5/5e/Waterloo_crispier_logo_transparent.png" alt="Waterloo iGEM CRISPieR Logo" class="img-responsive"/>
−
            </div>
 
−
            <div class="col-sm-2 text-center">
 
−
                <h2 class="orangetext no-border">sgRNA Exchange</h2>
 
 
             </div>
 
             </div>
 
             <div class="col-sm-3 text-center">
 
             <div class="col-sm-3 text-center">
−
                 <h2 class="bluetext no-border">Cas9 PAM Flexibility</h2>
+
                 <h2 class="orangetext no-border">Cas9 PAM Flexibility</h2>
 +
            </div>
 +
            <div class="col-sm-2 text-center">
 +
                <h2 class="bluetext no-border">Simple sgRNA Exchange</h2>
 
             </div>
 
             </div>
 
             <div class="col-sm-2 text-center">
 
             <div class="col-sm-2 text-center">

Revision as of 15:21, 16 September 2015

Waterloo iGEM CRISPieR Logo

Cas9 PAM Flexibility

Simple sgRNA Exchange

CRISPR Plant Defense

Re-engineering CRISPR-Cas9 with functional applications in eukaryotic systems

CRISPR-Cas9 is an exciting tool for synthetic biologists because it can target and edit genomes with unprecedented specificity. Our team is attempting to re-engineer CRISPR to make it more flexible and easier to use.

We’re making it easy to test different sgRNA designs: restriction sites added to the sgRNA backbone allow 20 nucleotide target sequences to be swapped without excessive cloning.

Additionally, we’re applying recent research on viable mutations within Cas9’s PAM-interacting domain to design (d)Cas9 variants that bind to novel PAM sites, moving towards the goal of a suite of variants that can bind any desired sequence. We believe our re-engineered CRISPR-Cas9 will give biologists increased ability to optimize targeting in many applications.

The application we chose to explore is a proof-of-concept antiviral system defending the model plant Arabidopsis thaliana against Cauliflower Mosaic Virus, which would benefit from testing a large number of possible sgRNAs in the viral genome.

Top